Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
NCT00096369
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
130
Enrollment
OTHER
Sponsor class
Stopped
accrual goal not met
Conditions
Breast Cancer
Interventions
DRUG:
tamoxifen citrate
Sponsor
University of Texas Southwestern Medical Center
Collaborators
[object Object]